3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
7
Ovarian Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Fallopian Tube Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Pancreatic Neoplasms
3
Mouth Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Mycosis Fungoides
2
Multiple Myeloma
2
Melanoma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoid Interstitial Pneumonia
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Colonic Neoplasms
2
Carcinoma
2
Brenner Tumor
2
Breast Neoplasms
2
Adenocarcinoma of Lung
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Interventions
Etoposide
3
daratumumab
2
Vincristine
2
Prednisone
2
Doxorubicin
2
Cyclophosphamide
2
prednylidene
1
pomalidomide
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Rituximab
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Dexamethasone
1
Cytarabine
1
Carmustine
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Plasmablastic Lymphoma
×
Disulfides
×
30 days
×
Clear all
No trials found.